LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (AMEX:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today results of its recent investments to acquire and advance its ClassPharmer™ product line. The Company has received revenues and purchased accounts receivable from its acquisition last year of certain assets of the former Bioreason, Inc., and Sage Informatics, LLC, that have exceeded the original acquisition costs.
